These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 5590471

  • 1. [Breast cancer. Cystic breast (fibroadenomatosis) and cancer].
    Myhre E.
    Tidsskr Nor Laegeforen; 1967 Dec 01; 87(23):1985-8. PubMed ID: 5590471
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Dyshormonal diseases of the breast].
    Ismaĭlov AKh.
    Khirurgiia (Mosk); 1978 Nov 01; (11):115-8. PubMed ID: 723157
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Quantitative morphological characteristics of the changes in the effector component of the immune system in dyshormonal hyperplasias and breast cancer].
    Abrakova EL.
    Vopr Onkol; 1982 Nov 01; 28(10):81-5. PubMed ID: 7147824
    [Abstract] [Full Text] [Related]

  • 6. [Improvement in the early diagnosis of precancerous conditions and breast cancer].
    Zhivetskiĭ AV, Zhivetskiĭ VA, Gerasimov BA.
    Khirurgiia (Mosk); 1982 May 01; (5):15-7. PubMed ID: 7115540
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Fibroadenomatosis of the breast (problems of classification, histology, and histogenesis)].
    Golovin DI, Rakhmanova LA.
    Arkh Patol; 1966 May 01; 28(11):3-15. PubMed ID: 6002049
    [No Abstract] [Full Text] [Related]

  • 10. [Prevention of cancer of the breast].
    Cappello F.
    Minerva Ginecol; 1971 Jul 13; 23(13):597-600. PubMed ID: 5122461
    [No Abstract] [Full Text] [Related]

  • 11. [Histochemical study of breast cystic dysplasias and fibroadenomas].
    Hernández F.
    Rev Med Univ Navarra; 1971 Sep 13; 15(3):167-71. PubMed ID: 4114904
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Results of preventive breast examinations in 1,000 professionally active women in the St. Gallen canton].
    Heyden S, Amgwerd R, Gloor F, Wild R, Bruderer E, Metzler B.
    Schweiz Med Wochenschr; 1974 Oct 26; 104(43):1525-9. PubMed ID: 4456577
    [No Abstract] [Full Text] [Related]

  • 16. [Use of infecundin in dyshormonal hyperplasia of the breast associated with ovarian dysfunction].
    Mezinova NN.
    Sov Med; 1975 Jun 26; (6):85-90. PubMed ID: 1162479
    [No Abstract] [Full Text] [Related]

  • 17. [Functional activity of the thyroid gland in cancer and precancerous diseases of the breast].
    Arber IN.
    Klin Khir (1962); 1967 Nov 26; 11():30-3. PubMed ID: 5617393
    [No Abstract] [Full Text] [Related]

  • 18. [Some aspects of fibrocystic breast disease].
    Mizia-Stec K, Zych F.
    Pol Merkur Lekarski; 1997 May 26; 2(11):303-6. PubMed ID: 9377675
    [Abstract] [Full Text] [Related]

  • 19. [Diagnosis of benign breast diseases. Clinical aspects].
    Junkermann H.
    Gynakologe; 1989 Aug 26; 22(4):226-9. PubMed ID: 2676757
    [No Abstract] [Full Text] [Related]

  • 20. Biochemical subgrouping of benign breast disease to define premalignant potential.
    Minton JP, Abou-Issa H, Elliot JB, Foecking MK, Roseman JM, Matthews RH.
    Surgery; 1981 Oct 26; 90(4):652-6. PubMed ID: 6269241
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.